A LGX 75mg (Braftovi 75 mg)
Generic Name: encorafenib
Pill with imprint A LGX 75mg is Beige / White, Capsule-shape and has been identified as Braftovi 75 mg. It is supplied by Array BioPharma Inc..
Braftovi is used in the treatment of colorectal cancer; melanoma, metastatic and belongs to the drug class multikinase inhibitors. Braftovi 75 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A LGX 75mg
Braftovi
- Generic Name
- encorafenib
- Imprint
- A LGX 75mg
- Strength
- 75 mg
- Color
- Beige / White
- Size
- 23.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Array BioPharma Inc.
- National Drug Code (NDC)
- 70255-0025
- Inactive Ingredients
-
copovidone,
poloxamer 188,
microcrystalline cellulose,
succinic acid,
silicon dioxide,
magnesium stearate,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
ferrosoferric oxide,
shellac,
propylene glycol
Note: Inactive ingredients may vary.
More about Braftovi (encorafenib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: multikinase inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.